A new study from scientists at the UCLA Health Jonsson Comprehensive Cancer Center helps explain why glioblastoma, one of the ...
Researchers at the Joint Department of Biomedical Engineering at UNC and North Carolina State University recently received a $3.15 million grant from the National Cancer Institute.
A new study from scientists at the UCLA Health Jonsson Comprehensive Cancer Center helps explain why glioblastoma, one of the most aggressive forms of brain cancer, becomes resistant to treatment, and ...
Trials with mice in whom the researchers implanted human glioblastoma cells have already shown that the treatment is very ...
A team led by researchers at the University of Toronto has uncovered new targets that could be the key to effectively treating glioblastoma, a lethal type of brain cancer. These targets were ...
UCLA researchers have developed a new approach to treating glioblastoma by combining genetic and functional profiling to predict tumor responses to therapies. The team showed promising results in ...
In 2016, cancer biologist Johanna Joyce of the Memorial Sloan Kettering Cancer Center published a study in Science that ...
Gliocidin selectively kills glioblastoma cells by inhibiting nucleotide synthesis, showing potential as a therapeutic option ...
Glioblastoma is the most common kind of malignant brain tumor in adults. So far, no treatment has been able to make this ...
Nov. 12, 2024 — Glioblastoma is the most common kind of malignant brain tumor in adults. So far, no treatment has been able to make this aggressive tumor permanently disappear. The tumor cells ...
Researchers have developed an innovative CAR T-cell therapy to combat glioblastoma, the most common malignant brain tumor in ...
However, it is a disease that needs attention. So, you should be aware of the signs of glioblastoma, which the World Health Organization defines as a grade IV cancer. Health Shots reached out to ...